BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/15/2022 11:41:26 AM | Browse: 313 | Download: 909
 |
Received |
|
2022-08-17 15:33 |
|
Peer-Review Started |
|
2022-08-10 13:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-05 06:50 |
|
Revised |
|
2022-10-18 15:44 |
|
Second Decision |
|
2022-12-01 03:25 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-12-01 22:39 |
|
Articles in Press |
|
2022-12-01 22:39 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-12-06 00:35 |
|
Publish the Manuscript Online |
|
2022-12-15 11:41 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Observational Study |
| Article Title |
Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Amir Bashkin, Mona Shehadeh, Lina Shbita, Kamil Namoura, Ronza Haiek, Elena Kuyantseva, Yousef Boulos, Orly Yakir and Etty Kruzel-Davila |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amir Bashkin, MD, Director, Director, Doctor, Doctor, Researcher, Department of Diabetes, Endocrinology, and Metabolism, Galilee Medical Center, Route 89, Nahariya 2210001, Israel. amirb@gmc.gov.il |
| Key Words |
Diabetes mellitus; COVID-19; Albuminuria; Severity; Chronic kidney disease; Immunomodulation |
| Core Tip |
Type 2 diabetes mellitus and its risk factors are considered to be contributors to severe coronavirus disease 2019 (COVID-19). In this study, we analyzed our single-center clinical data of adults with type 2 diabetes between September 2020 and May 2021 to determine the impact of risk factors on severity of COVID-19 pneumonia. Surprisingly, we found that moderate-range pre-hospitalization albuminuria was associated with reduced risk of severe COVID-19 pneumonia. Further studies are needed to explore this association and pathogenesis relating to immunomodulation, which may indicate a biomarker for patients at reduced risk for COVID-19-related deterioration that may translate to therapeutic interventions. |
| Publish Date |
2022-12-15 11:41 |
| Citation |
Bashkin A, Shehadeh M, Shbita L, Namoura K, Haiek R, Kuyantseva E, Boulos Y, Yakir O, Kruzel-Davila E. Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia. World J Diabetes 2022; 13(12): 1154-1167 |
| URL |
https://www.wjgnet.com/1948-9358/full/v13/i12/1154.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v13.i12.1154 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
